Cheng WY, Ou Yang TH, Anastassiou D. Development of a prognostic model for breast cancer survival in an open challenge environment. Sci Transl Med. 2013 Apr 17;5(181):181ra50. (This research article describes the winning model of the Sage Bionetworks/DREAM Breast Cancer Prognosis Challenge, which is the cover story of the journal. The winning model is also summarized in NPG's Science-Business eXchange and featured in a Research Highlight in Nature Reviews Cancer, Vol. 13, June 2013.)
Cheng WY, Ou Yang TH, Anastassiou D. Biomolecular events in cancer revealed by attractor metagenes. PLoS Comput. Biol. 2013;9(2):e1002920.
Cheng WY, Kandel JJ, Yamashiro DJ, Canoll P, Anastassiou D. A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. PLoS ONE. 2012;7(4):e34705.
Andreopoulos B, Anastassiou D. Integrated analysis reveals hsa-miR-142 as a representative of a lymphocyte-specific gene expression and methylation signature. Cancer Inform. 2012;11:61-75.
Anastassiou D, Rumjantseva V, Cheng WY, Huang J, Canoll P, Yamashiro DJ, Kandel JJ. Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. BMC Cancer. 2011 Dec 30;11:529.
Kim H, Watkinson J, Varadan V, Anastassiou D. Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics. 2010 Nov 3;3(51).